During Wednesday’s Afternoon trade, Shares of Facebook Inc (NASDAQ:FB), declined -0.16% to $105.51. The firm opened its current trade at $106.33, and as of now, it is trading at $105.56. The total volume traded for the day is 8.20M shares, as compared to its average daily volume of 28.38M shares. The stock is floating in a range of $105.10 - $106.60. The stock holds the market capitalization of $299.60B.
Mark Zuckerberg and a pregnant Priscilla Chan.
Long before it was trendy, Facebook cultivated a company culture where it’s taboo for dads not to take parental leave, and CEO Mark Zuckerberg’s recent declaration cements Facebook’s status as a compelling case study for how to make parental leave policies work, according to Business Insider
While it’s unclear how much time he plans to take during the year following his child’s birth — many dads at Facebook split their time rather than take the available four months at once — last week Zuckerberg declared on Facebook that he would take two months of leave following the arrival of his and wife Priscilla Chan’s daughter, citing the benefits that come when working parents take time to be with their newborns.
The news comes at a critical time for American parents: Presently the US is the only developed nation in the world that doesn’t ensure any paid time off for new moms, according to a report from the International Labor Organization.
Facebook, Inc. operates as a social networking company worldwide. It provides a set of development tools and application programming interfaces that enable developers to integrate with Facebook to create mobile and Web applications.
Shares of KaloBios Pharmaceuticals Inc (NASDAQ:KBIO), gained 35.16% to $25.32.
KBIO stock is now trading at $25.87, having a volume of 5.47M shares. The year-to-date (YTD) performance of KBIO stock reflects that it is 79.26%.
During the past month, the stock gain 11116.18%, bringing three-month performance to 1233.87% and six-month performance to 482.94%.
The 52-week range of the share price is from $0.44 – $45.82.
Its earnings per share(EPS) was -$8.11. The company has total market capitalization of $67.04M and a total of 4.12 million outstanding shares.
KaloBios Pharmaceuticals, Inc., a biopharmaceutical company, develops monoclonal antibody therapeutics for the treatment of cancer in the United States. The company’s product candidates comprise KB004, which is in a Phase II clinical trial for the treatment of myelodysplastic syndrome and myelofibrosis; and KB003 that accomplished Phase II clinical trial to treat chronic myelomonocytic leukemia, an orphan oncology indication. KaloBios Pharmaceuticals, Inc. was founded in 2000 and is headquartered in South San Francisco, California.
Finally, Shares of Amazon.com, Inc (NASDAQ:AMZN), gained 0.47%, and is now trading at $674.28.
Earlier recently at a press conference with Governor Charlie Baker, Amazon.com, Inc. (AMZN) declared plans to open a fulfillment center in Fall River, Mass. This facility will bring more than 500 full-time jobs to the area. These jobs will be eligible for comprehensive benefits on day one that comprise health insurance, 401(k) with 50 percent match, bonuses, company stock awards and a network of support to assist ensure employees succeed.
“Our footprint in Massachusetts continues to grow. We presently employ hundreds of developers, engineers, and scientists. Now we will add hundreds of additional full-time associates in our first fulfillment center in the state,” said Mike Roth, Amazon’s vice president of North America operations. “Massachusetts is a great place to do business and we are excited to be creating more jobs.”
Amazon presently operates a sortation center in Stoughton and also has research and technology offices throughout the state.
Amazon.com, Inc. operates as an online retailer in North America and internationally. It operates through the North America, International, and Amazon Web Services (AWS) segments. The company serves consumers through retail websites, such as amazon.com, amazon.ca, and amazon.com.mx, which primarily comprise merchandise and content purchased for resale from vendors and those offered by third-party sellers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.